返回 Agenda
PMDA Updates
Session Chair(s)
Nobumasa Nakashima
Professor
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Dr. Yasuhiro Fujiwara, a new chief executive, has announced a new policy “4Fs”. PMDA is working effectively toward the realization of his goal. In this session, PMDA will share the latest details regarding its policies and initiatives.
Learning Objective : (1) To raise awareness of the latest information regarding PMDA and Japanese regulations (2) To foster dialogue between participants and senior PMDA officials concerning drug/device regulatory concerns
Speaker(s)
Regulatory Update from the MHLW’s Points
Fumi Yamamoto
Ministry of Health, Labour and Welfare (MHLW), Japan
Councilor for Pharmaceutical Affairs, Minister’s Secretariat
Recent Topics in PMDA-Including the Fight Against COVID-19
Yasuhiro Fujiwara, MD, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Progress of Center for Regulatory Science
Hiroshi Suzuki, PHARMD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director of Center for Regulatory Science